133 related articles for article (PubMed ID: 31630877)
21. Prevalence and clinical profiles of 'autoantibody-negative' systemic sclerosis subjects.
Hudson M; Satoh M; Chan JY; Tatibouet S; Mehra S; Baron M; Fritzler M;
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-127-32. PubMed ID: 24144389
[TBL] [Abstract][Full Text] [Related]
22. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
Bonaguri C; Melegari A; Ballabio A; Parmeggiani M; Russo A; Battistelli L; Aloe R; Trenti T; Lippi G
Autoimmun Rev; 2011 Nov; 11(1):1-5. PubMed ID: 21741498
[TBL] [Abstract][Full Text] [Related]
23. Application of linear discriminant analysis in performance evaluation of extractable nuclear antigen immunoassay systems in the screening and diagnosis of systemic autoimmune rheumatic diseases.
Pi D; de Badyn MH; Nimmo M; White R; Pal J; Wong P; Phoon C; O'Connor D; Pi S; Shojania K
Am J Clin Pathol; 2012 Oct; 138(4):596-603. PubMed ID: 23010715
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
25. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
[TBL] [Abstract][Full Text] [Related]
26. Detection of antinuclear antibodies (ANA), antibodies to double stranded DNA (anti-dsDNA) and antibodies to extractable nuclear antigens (anti-ENA) in Greek patients.
Stamouli M; Skliris A; Reppa D; Maganaki E; Totos G
Clin Lab; 2013; 59(3-4):283-91. PubMed ID: 23724616
[TBL] [Abstract][Full Text] [Related]
27. Analytical and clinical performance of different platforms simultaneously detecting 15 antinuclear antibodies.
Qin Y; Fan C; Wang Y; Feng M; Liang Z; Zhao X; Gao C; Luo J
J Clin Lab Anal; 2022 Jul; 36(7):e24554. PubMed ID: 35708068
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of non-organ-specific autoantibodies in patients with pemphigus vulgaris.
Blondin DA; Zhang Z; Shideler KK; Hou H; Fritzler MJ; Mydlarski PR
J Cutan Med Surg; 2009; 13(2):82-7. PubMed ID: 19298776
[TBL] [Abstract][Full Text] [Related]
29. Detection and identification of antinuclear antibodies (ANA) in a large community hospital.
Verstegen G; Duyck MC; Meeus P; Ravelingien I; De Vlam K
Acta Clin Belg; 2009; 64(4):317-23. PubMed ID: 19810418
[TBL] [Abstract][Full Text] [Related]
30. Novel diagnostic and clinical aspects of anti-PCNA antibodies detected by novel detection methods.
Mahler M; Silverman ED; Fritzler MJ
Lupus; 2010 Nov; 19(13):1527-33. PubMed ID: 20647252
[TBL] [Abstract][Full Text] [Related]
31. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
[TBL] [Abstract][Full Text] [Related]
32. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
Tipu HN; Bashir MM
J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
[TBL] [Abstract][Full Text] [Related]
33. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
[TBL] [Abstract][Full Text] [Related]
34. Practical Aspects of Introduction of Multiplex Bead Technology into the Routine Diagnostic Immunology Laboratory.
Swana G; Kariyawasam D; Carroll P; Karim MY
Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532090
[TBL] [Abstract][Full Text] [Related]
35. Clinical use of anti-DFS70 autoantibodies.
Kang SY; Lee WI; Kim MH; La Jeon Y
Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
[TBL] [Abstract][Full Text] [Related]
36. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
[TBL] [Abstract][Full Text] [Related]
37. Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells.
Feist E; Brychcy M; Hausdorf G; Hoyer B; Egerer K; Dörner T; Kuckelkorn U; Burmester GR
Ann Rheum Dis; 2007 Jan; 66(1):5-11. PubMed ID: 16815863
[TBL] [Abstract][Full Text] [Related]
38. Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis.
Albon S; Bunn C; Swana G; Karim Y
J Immunol Methods; 2011 Feb; 365(1-2):126-31. PubMed ID: 21184759
[TBL] [Abstract][Full Text] [Related]
39. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.
Koenig M; Fritzler MJ; Targoff IN; Troyanov Y; Senécal JL
Arthritis Res Ther; 2007; 9(4):R78. PubMed ID: 17688695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]